Moreover, prior studies in pancreatic cancer [56], lung cancer [57], breast cancer [58], and CRC [59] demonstrate that miR‐192 regulates expression of SERPINE1, RB‐1, BMP‐6, and DHFR and functions as a tumor suppressor. This evidence concerns the gene RB1 and colorectal carcinoma.